results of a phase ii clinical trial of vindesine sulfate in differentiated carcinoma of the upper respiratory and digestive tracts demonstrated good efficacy , with 6 objective responses in the 14 patients with interpretable reports several toxic reactions were observed , three patients developing polyneuritis of the upper and lower limbs after doses of 33 to 40 mg of dva .
C0042683
vindesine sulfate
C0042682
dva